DARIOHEALTH CORP. (NASDAQ:DRIO) Files An 8-K Material Modification to Rights of Security Holders

0
DARIOHEALTH CORP. (NASDAQ:DRIO) Files An 8-K Material Modification to Rights of Security Holders

DARIOHEALTH CORP. (NASDAQ:DRIO) Files An 8-K Material Modification to Rights of Security Holders
Item 3.03

On July 8, 2019, DarioHealth Corp. (“the Company”) and the holders of certain pre-funded warrants to purchase up to 7,175,525 shares of the Company’s common stock (the “Pre-Funded Warrants”) that were issued and sold on May 24, 2019 to the Company’s previously announced public offering, agreed to amend the terms of the Pre-Funded Warrants to include a $100,000 limitation to any potential buy-in penalty as provided in the Pre-Funded Warrants (the “Amendment”).

The Amendment is filed as Exhibit 4.1 hereto and is incorporated herein by reference. The foregoing description of the terms of the Amendment is qualified in its entirety by reference to such exhibit.

(d) Exhibits.

4.1 Form of Amendment to Pre-Funded Warrant


DarioHealth Corp. Exhibit
EX-4.1 2 tv524933_ex4-1.htm EXHIBIT 4.1   Exhibit 4.1   AMENDMENT NO. 1 TO PRE-FUNDED WARRANT   This AMENDMENT NO. 1 TO PRE-FUNDED WARRANT (this “Amendment”) is effective as of July __,…
To view the full exhibit click here

About DARIOHEALTH CORP. (NASDAQ:DRIO)

DarioHealth Corp, formerly Labstyle Innovations Corp, is a digital health (mHealth) company. The Company is engaged in developing and commercializing a technology providing consumers with laboratory-testing capabilities using smart phones and other mobile devices. The Company’s product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with a pocket-sized, blood glucose monitoring device, Dario Smart Meter. The Dario product is a digital diabetes management solution utilizing its technology delivered through a software application available for iPhone or Android and cloud-based data services with a blood glucose monitoring system device. Dario allows users to record, analyze, transmit and store various data points, such as glucose level, insulin and carbohydrate intake. It markets the Dario Smart Diabetes Management Solution in the Netherlands and New Zealand.